Associate Professor Wendy Cooper

Journal Articles

• Chu, G., Linton, A., Kao, S., Klebe, S., Adelstein, S., Yeo, D., Rasko, J. and Cooper, W. (2023), 'High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma', Histopathology, vol 83, no 2 , pp 202 - 210.
• Fernando, C., Jayasekara, W., Inampudi, C., Kohonen-Corish, M., Cooper, W., Beilharz, T., Josephs, T., Garama, D. and Gough, D. (2023), 'A STAT3 protein complex required for mitochondrial mRNA stability and cancer', Cell Reports, vol 42, no 9 .
• Roden, A., Judge, M., den Bakker, M., Fang, W., Jain, D., Marx, A., Moreira, A., Rajan, A., Stroebel, P., Szolkowska, M. and Cooper, W. (2023), 'Dataset for reporting of thymic epithelial tumours : recommendations from the International Collaboration on Cancer Reporting (ICCR)', Histopathology, vol 83, no 6 .
• Dacic, S., Travis, W., Redman, M., Saqi, A., Cooper, W., Borczuk, A., Chung, J., Glass, C., Lopez, J., Roden, A., Sholl, L., Weissferdt, A., Posadas, J., Walker, A., Zhu, H., Wijeratne, M., Connolly, C., Wynes, M., Bota-Rabassedas, N., Sanchez-Espiridion, B., Lee, J., Berezowska, S., Chou, T., Kerr, K., Nicholson, A., Poleri, C., Schalper, K., Tsao, M., Carbone, D., Ready, N., Cascone, T., Heymach, J., Sepesi, B., Shu, C., Rizvi, N., Sonett, J., Altorki, N., Provencio, M., Bunn, P., Kris, M., Belani, C., Kelly, K., Wistuba, I. and IASLC Pathology Committee, .. (2023), 'International Association for the Study of Lung Cancer study of reproducibility in assessment of pathologic response in resected lung cancers after neoadjuvant therapy', Journal of Thoracic Oncology, vol 18, no 10 , pp 1290 - 1302.
• Yu, S., Hsiao, Y., Cooper, W., Choi, Y., Aviles-Salas, A., Chou, T., Coudry, R., Raskin, G., Fox, S., Huang, C., Jeon, Y., Ko, Y., Ku, W., Kwon, G., Leslie, C., Lin, M., Lou, P., Scapulatempo-Neto, C., Ramirez, S., Savelov, N., Shim, H., Torres, C., Cunha, I., Zavalishina, L. and Chen, Y. (2023), 'The ring study : an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer', Pathology, vol 55, no 1 , pp 19 - 30.
• Habashy, P., Lea, V., Wilkinson, K., Wang, B., Wu, X., Roberts, T., Ng, W., Rutland, T., Po, J., Becker, T., Descallar, J., Lee, M., Mackenzie, S., Gupta, R., Cooper, W., Lim, S., Chua, W. and Lee, C. (2023), 'KRAS and BRAF mutation rates and survival outcomes in colorectal cancer in an ethnically diverse patient cohort', International Journal of Molecular Sciences, vol 24, no 24 .
• Fielder, T., Butler, J., Tierney, G., Holmes, M., Lam, K., Satgunaseelan, L., Colebatch, A., Mahar, A., Gupta, R., O'Toole, S. and Cooper, W. (2022), 'ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1', Pathology, vol 54, no 4 , pp 399 - 403.
• Clynick, B., Corte, T., Jo, H., Stewart, I., Glaspole, I., Grainge, C., Maher, T., Navaratnam, V., Hubbard, R., Hopkins, P., Reynolds, P., Chapman, S., Zappala, C., Keir, G., Cooper, W., Mahar, A., Ellis, S., Goh, N., De Jong, E., Cha, L., Tan, D., Leigh, L., Oldmeadow, C., Walters, H., Jenkins, R. and Moodley, Y. (2022), 'Biomarker signatures for progressive idiopathic pulmonary fibrosis', European Respiratory Journal, vol 59, no 3 .
• Woodford, R., Zhou, D., Lord, S., Marschner, I., Cooper, W., Lewis, C., John, T., Yang, J. and Lee, C. (2022), 'PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer', Future Oncology, vol 18, no 14 , pp 1793 - 1799.
• Ruffini, E., Rami-Porta, R., Huang, J., Ahmad, U., Appel, S., Bille, A., Boubia, S., Brambilla, C., Cangir, A., Cilento, V., Detterbeck, F., Falkson, C., Fang, W., Filosso, P., Giaccone, G., Girard, N., Guerrera, F., Infante, M., Kim, D., Lucchi, M., Marino, M., Marom, E., Nicholson, A., Okumura, M., Rimner, A., Simone, C., Asamura, H., Rusch, V., Araujo, L., Beer, D., Bertoglio, P., Beyruti, R., Brambilla, E., Cangir, A., Connolly, C., Darling, G., Dibaba, D., D?Journo, X., Eberhardt, W., Erasmus, J., Fennell, D., Fong, K., Galateau-Salle, F., Gill, R., Giroux, D., Giuliani, M., Goo, J., Hirsch, F., Hoffman, H., Cooper, W. and et al, .. (2022), 'The International Association for The Study of Lung Cancer thymic epithelial tumor staging project : unresolved issues to be addressed for the next ninth edition of the TNM Classification of Malignant Tumors', Journal of Thoracic Oncology, vol 17, no 6 , pp 838 - 851.
• Cho, D., Lord, S., Simes, J., Cooper, W., Friedlander, M., Bae, S. and Lee, C. (2022), 'Next-generation sequencing, should I use anti-HER2 therapy for HER2-amplified tumors off-label? : illustrating an extrapolation framework', Therapeutic Advances in Medical Oncology, vol 14 , pp 1 - 11.
• Potter, A., Colebatch, A., Rawson, R., Ferguson, P., Cooper, W., Gupta, R., O'Toole, S., Saw, R., Ch'ng, S., Menzies, A., Long, G. and Scolyer, R. (2022), 'Pathologist initiated reflex BRAF mutation testing in metastatic melanoma : experience at a specialist melanoma treatment centre', Pathology, vol 54, no 5 , pp 526 - 532.
• Cooper, W., Mahar, A., Myers, J., Grainge, C., Corte, T., Williamson, J., Vallely, M., Lai, S., Mulyadi, E., Torzillo, P., Phillips, M., Lau, E., Raghu, G. and Troy, L. (2021), 'Cryobiopsy for identification of usual interstitial pneumonia and other interstitial lung disease features : further lessons from COLDICE, a prospective multi-center study', American Journal of Respiratory and Critical Care Medicine, vol 203, no 10 , pp 1306 - 1313.
• Pang, J., Castles, B., Byrne, D., Button, P., Hendry, S., Lakhani, S., Sivasubramaniam, V., Cooper, W., Armes, J., Millar, E., Raymond, W., Roberts-Thomson, S., Kumar, B., Burr, M., Selinger, C., Harvey, K., Chan, C., Beith, J., Clouston, D., O'Toole, S. and Fox, S. (2021), 'SP142 PD-L1 scoring shows high interobserver and intraobserver agreement in triple-negative breast carcinoma but overall low percentage agreement with other PD-L1 clones SP263 and 22C3', American Journal of Surgical Pathology, vol 45, no 8 , pp 1108 - 1117.
• Paver, E., Cooper, W., Colebatch, A., Ferguson, P., Hill, S., Lum, T., Shin, J., O'Toole, S., Anderson, L., Scolyer, R. and Gupta, R. (2021), 'Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours : a guide to immunohistochemistry implementation and interpretation', Pathology, vol 53, no 2 , pp 141 - 156.
• Holmes, M., Mahar, A., Lum, T., Kao, S. and Cooper, W. (2021), 'Real-world programmed death-ligand 1 prevalence rates in non-small cell lung cancer : correlation with clinicopathological features and tumour mutation status', Journal of Clinical Pathology, vol 74, no 2 , pp 123 - 128.
• Liu, J., Itchins, M., Nagrial, A., Cooper, W., De Silva, M., Barnet, M., Varikatt, W., Sivasubramaniam, V., Davis, A., Gill, A., Blinman, P., Lee, K., Hui, R., Gao, B., Pavlakis, N., Clarke, S., Lee, J., Boyer, M. and Kao, S. (2021), 'Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors', Lung Cancer, vol 155 , pp 28 - 33.
• Paver, E., O'Toole, S., Cheng, X., Mahar, A. and Cooper, W. (2021), 'Updates in the molecular pathology of non-small cell lung cancer', Seminars in Diagnostic Pathology, vol 38, no 5 , pp 54 - 61.
• Mino-Kenudson, M., Le Stang, N., Daigneault, J., Nicholson, A., Cooper, W., Roden, A., Moreira, A., Thunnissen, E., Papotti, M., Pelosi, G., Motoi, N., Poleri, C., Brambilla, E., Redman, M., Jain, D., Dacic, S., Yatabe, Y., Tsao, M., Lopez-Rios, F., Botling, J., Chen, G., Chou, T., Hirsch, F., Beasley, M., Borczuk, A., Bubendorf, L., Chung, J., Hwang, D., Lin, D., Longshore, J., Noguchi, M., Rekhtman, N., Sholl, L., Travis, W., Yoshida, A., Wynes, M., Wistuba, I., Kerr, K. and Lantuejoul, S. (2021), 'The International Association for the Study of Lung Cancer Global Survey on programmed death-ligand 1 testing for NSCLC', Journal of Thoracic Oncology, vol 16, no 4 , pp 686 - 696.
• Aggarwal, C., Bubendorf, L., Cooper, W., Illei, P., Nunes, P., Ong, B., Tsao, M., Yatabe, Y. and Kerr, K. (2021), 'Molecular testing in stage I-III non-small cell lung cancer : approaches and challenges', Lung Cancer, vol 162 , pp 42 - 53.
• Davis, A., Cooper, W., Boyer, M., Lee, J., Pavlakis, N. and Kao, S. (2021), 'Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutations', Immunotherapy, vol 13, no 11 , pp 941 - 952.
• Meyer, N., Cooper, W., Kirwan, P., Garsia, R., Dunkley, S. and Gracey, D. (2021), 'Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia : a successfully managed with rituximab : case report and review of the literature', BMC Nephrology, vol 22, no 1 .
• Hendry, S., Byrne, D., Christie, M., Steinfort, D., Irving, L., Wagner, C., Ellwood, T., Cooper, W. and Fox, S. (2020), 'Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimens', Cytopathology, vol 31, no 2 , pp 90 - 95.
• Itchins, M., Lau, B., Hudson, A., Westman, H., Xia, C., Hayes, S., Howell, V., Rodriguez, M., Cooper, W., Wei, H., Buckland, M., Li, B., Li, M., Rathi, V., Fox, S., Gill, A., Clarke, S., Boyer, M. and Pavlakis, N. (2020), 'ALK-rearranged non-small cell lung cancer in 2020 : real-world triumphs in an era of multigeneration ALK-inhibitor sequencing informed by drug resistance profiling', Oncologist, vol 25, no 8 , pp 641 - 649.
• Ahmadzada, T., Cooper, W., Holmes, M., Mahar, A., Westman, H., Gill, A., Nordman, I., Yip, P., Pal, A., Zielinski, R., Pavlakis, N., Nagrial, A., Daneshvar, D., Brungs, D., Karikios, D., Aleksova, V., Burn, J., Asher, R., Grau, G., Hosseini-Beheshti, E., Reid, G., Clarke, S. and Kao, S. (2020), 'Retrospective evaluation of the use of pembrolizumab in malignant mesothelioma in a real-world Australian population', JTO Clinical and Research Reports, vol 1, no 4 .
• Troy, L., Grainge, C., Corte, T., Williamson, J., Vallely, M., Cooper, W., Mahar, A., Myers, J., Lai, S., Mulyadi, E., Torzillo, P., Phillips, M., Jo, H., Webster, S., Lin, Q., Rhodes, J., Salamonsen, M., Wrobel, J., Harris, B., Don, G., Wu, P., Ng, B., Oldmeadow, C., Raghu, G., Lau, E., Arnold, D., Cao, C., Cashmore, A., Cleary, S., Evans, T., French, B., Geis, M., Glenn, L., Hibbert, M., Ing, A., James, A., Meredith, G., Merry, C., Pudipeddi, A., Saghaie, T., Thomas, R., Thomson, C. and Twaddell, S. (2020), 'Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE) : a prospective, comparative study', The Lancet Respiratory Medicine, vol 8, no 2 , pp 171 - 181.
• Moreira, A., Ocampo, P., Xia, Y., Zhong, H., Russell, P., Minami, Y., Cooper, W., Yoshida, A., Bubendorf, L., Papotti, M., Pelosi, G., Lopez-Rios, F., Kunitoki, K., Ferrari-Light, D., Sholl, L., Beasley, M., Borczuk, A., Botling, J., Brambilla, E., Chen, G., Chou, T., Chung, J., Dacic, S., Jain, D., Hirsch, F., Hwang, D., Lantuejoul, S., Lin, D., Longshore, J., Motoi, N., Noguchi, M., Poleri, C., Rekhtman, N., Tsao, M., Thunnissen, E., Travis, W., Yatabe, Y., Roden, A., Daigneault, J., Wistuba, I., Kerr, K., Pass, H., Nicholson, A. and Mino-Kenudson, M. (2020), 'A grading system for invasive pulmonary adenocarcinoma : a proposal from the International Association for the Study of Lung Cancer Pathology Committee', Journal of Thoracic Oncology, vol 15, no 10 , pp 1599 - 1610.
• Smith, M., Hariri, L., Mino-Kenudson, M., Dacic, S., Attanoos, R., Borczuk, A., Colby, T., Cooper, W., Jones, K., Leslie, K., Mahar, A., Larsen, B., Cavazza, A., Fukuoka, J., Roden, A., Sholl, L., Tazelaar, H., Churg, A. and Beasley, M. (2020), 'Histopathologic assessment of suspected idiopathic pulmonary fibrosis : where we are and where we need to go', Archives of Pathology and Laboratory Medicine, vol 144, no 12 , pp 1477 - 1489.
• Li, Z., Abadir, E., Lee, K., Clarke, C., Bryant, C., Cooper, W., Pietersz, G., Favaloro, J., Silveira, P., Hart, D., Ju, X. and Clark, G. (2020), 'Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody', Clinical and Translational Immunology, vol 9, no 7 .
• Sholl, L., Hirsch, F., Hwang, D., Botling, J., Lopez-Rios, F., Bubendorf, L., Mino-Kenudson, M., Roden, A., Beasley, M., Borczuk, A., Brambilla, E., Chen, G., Chou, T., Chung, J., Cooper, W., Dacic, S., Lantuejoul, S., Jain, D., Lin, D., Minami, Y., Moreira, A., Nicholson, A., Noguchi, M., Papotti, M., Pelosi, G., Poleri, C., Rekhtman, N., Tsao, M., Thunnissen, E., Travis, W., Yatabe, Y., Yoshida, A., Daigneault, J., Zehir, A., Peters, S., Wistuba, I., Kerr, K. and Longshore, J. (2020), 'The promises and challenges of tumor mutation burden as an immunotherapy biomarker : a perspective from the International Association for the Study of Lung Cancer Pathology Committee', Journal of Thoracic Oncology, vol 15, no 9 , pp 1409 - 1424.
• Lantuejoul, S., Sound-Tsao, M., Cooper, W., Girard, N., Hirsch, F., Roden, A., Lopez-Rios, F., Jain, D., Chou, T., Motoi, N., Kerr, K., Yatabe, Y., Brambilla, E., Longshore, J., Papotti, M., Sholl, L., Thunnissen, E., Rekhtman, N., Borczuk, A., Bubendorf, L., Minami, Y., Beasley, M., Botling, J., Chen, G., Chung, J., Dacic, S., Hwang, D., Lin, D., Moreira, A., Nicholson, A., Noguchi, M., Pelosi, G., Poleri, C., Travis, W., Yoshida, A., Daigneault, J., Wistuba, I. and Mino-Kenudson, M. (2020), 'PD-L1 testing for lung cancer in 2019 : perspective from the IASLC Pathology Committee', Journal of Thoracic Oncology, vol 15, no 4 , pp 499 - 519.
• Vargas, A., Selinger, C., Satgunaseelan, L., Cooper, W., Gupta, R., Stalley, P., Brown, W., Soper, J., Schatz, J., Boyle, R., Thomas, D., Tattersall, M., Bhadri, V., Maclean, F., Bonar, F., Scolyer, R., Karim, R., McCarthy, S., Mahar, A. and O'Toole, S. (2019), 'FISH analysis of selected soft tissue tumors : diagnostic experience in a tertiary center', Asia Pacific Journal of Clinical Oncology, vol 15, no 1 , pp 38 - 47.
• Luk, P., Selinger, C., Cooper, W., Mahar, A., Palme, C., O?Toole, S., Clark, J. and Gupta, R. (2019), 'Clinical utility of in situ hybridization assays in head and neck neoplasms', Head and Neck Pathology, vol 13, no 3 , pp 397 - 414.
• Ahmadzada, T., Lee, K., Clarke, C., Cooper, W., Linton, A., McCaughan, B., Asher, R., Clarke, S., Reid, G. and Kao, S. (2019), 'High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes', Lung Cancer, vol 130 , pp 35 - 41.
• Colebatch, A., Dobrovic, A. and Cooper, W. (2019), 'TERT gene : its function and dysregulation in cancer', Journal of Clinical Pathology, vol 72, no 4 , pp 281 - 284.
• Burgess, A., Goon, K., Brannan, J., Attia, J., Palazzi, K., Oldmeadow, C., Corte, T., Glaspole, I., Goh, N., Keir, G., Allan, H., Chapman, S., Cooper, W., Ellis, S., Hopkins, P., Moodley, Y., Reynolds, P., Zappala, C., Macansh, S. and Grainge, C. (2019), 'Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing', Respirology, vol 24, no 10 , pp 988 - 995.
• Jo, H., Corte, T., Glaspole, I., Grainge, C., Hopkins, P., Moodley, Y., Reynolds, P., Chapman, S., Walters, H., Zappala, C., Allan, H., Keir, G., Cooper, W., Mahar, A., Ellis, S., Macansh, S. and Goh, N. (2019), 'Gastroesophageal reflux and antacid therapy in IPF : analysis from the Australia IPF Registry', BMC Pulmonary Medicine, vol 19, no 1 .
• Woodford, R., Loh, Y., Lee, J., Cooper, W., Marschner, I., Lewis, C., Millward, M., Lord, S., Gralla, R., Yang, J., Mok, T. and Lee, C. (2019), 'Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer', Future Oncology, vol 15, no 20 , pp 2371 - 2383.
• Jo, H., Glaspole, I., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Chapman, S., Walters, E., Zappala, C., Allan, H., Macansh, S., Grainge, C., Keir, G., Hayen, A., Henderson, D., Klebe, S., Heinze, S., Miller, A., Rouse, H., Duhig, E., Cooper, W., Mahar, A., Ellis, S., McCormack, S., Ng, B., Godbolt, D. and Corte, T. (2019), 'Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice : analysis from the Australian Idiopathic Pulmonary Fibrosis Registry', Respirology, vol 24, no 4 , pp 361 - 368.
• Hendry, S., Byrne, D., Wright, G., Young, R., Sturrock, S., Cooper, W. and Fox, S. (2018), 'Comparison of four PD-L1 immunohistochemical assays in lung cancer', Journal of Thoracic Oncology, vol 13, no 3 , pp 367 - 376.
• Lee, C., Man, J., Lord, S., Cooper, W., Links, M., Gebski, V., Herbst, R., Gralla, R., Mok, T. and Yang, J. (2018), 'Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non-small cell lung carcinoma : a systematic review and meta-analysis', JAMA Oncology, vol 4, no 2 , pp 210 - 216.
• Jo, H., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., Reynolds, P., Walters, H., Zappala, C., Grainge, C., Allan, H., Macansh, S. and Corte, T. (2018), 'Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment : analysis from the Australian IPF registry', BMC Pulmonary Medicine, vol 18 .
• Gupta, R., Cooper, W., Selinger, C., Mahar, A., Anderson, L., Buckland, M. and O'Toole, S. (2018), 'Fluorescent in situ hybridization in surgical pathology practice', Advances in Anatomic Pathology, vol 25, no 4 , pp 223 - 237.
• Li, Z., Ju, X., Lee, K., Clarke, C., Hsu, J., Abadir, E., Bryant, C., Pears, S., Sunderland, N., Heffernan, S., Hennessy, A., Lo, T., Pietersz, G., Kupresanin, F., Fromm, P., Silveira, P., Tsonis, C., Cooper, W., Cunningham, I., Brown, C., Clark, G. and Hart, D. (2018), 'CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma', Haematologica, vol 103, no 4 , pp 655 - 665.
• Solinas, A., Mahar, A., Cooper, W., Thompson, J., Spillane, A. and Scolyer, R. (2018), 'Pigmented Paget's disease of the nipple mistaken for melanoma in situ : a diagnostic pitfall for the unwary', Pathology, vol 50, no 3 , pp 364 - 367.
• Cooper, W., Barnet, M., Kao, S. and Scolyer, R. (2018), 'Biomarkers that predict response to immunotherapy : no magic bullet', Cancer Forum, vol 42, no 1 , pp 92 - 101.
• Barnet, M., Blinman, P., Cooper, W., Boyer, M., Kao, S. and Goodnow, C. (2018), 'Understanding immune tolerance of cancer : re-purposing insights from fetal allografts and microbes', BioEssays, vol 40, no 8 .
• Barnet, M., Cooper, W., Boyer, M. and Kao, S. (2018), 'Immunotherapy in non-small cell lung cancer : shifting prognostic paradigms', Journal of Clinical Medicine, vol 7, no 6 .
• Ahmadzada, T., Kao, S., Reid, G., Boyer, M., Mahar, A. and Cooper, W. (2018), 'An update on predictive biomarkers for treatment selection in non-small cell lung cancer', Journal of Clinical Medicine, vol 7, no 6 .
• Itchins, M., Hayes, S., Gill, A., Cooper, W., O'Connell, R., Howell, V., Clarke, S. and Pavlakis, N. (2018), 'Pattern of care and survival of anaplastic lymphoma kinase rearranged non-small cell lung cancer (ALK+ NSCLC) in an Australian Metropolitan Tertiary Referral Centre : a retrospective cohort analysis', Asia-Pacific Journal of Clinical Oncology, vol 14, no 5 , pp 275 - 282.
• Bui, K., Cooper, W., Kao, S. and Boyer, M. (2018), 'Targeted molecular treatments in non-small cell lung cancer : a clinical guide for oncologists', Journal of Clinical Medicine, vol 7, no 8 .
• Luk, P., Selinger, C., Mahar, A. and Cooper, W. (2018), 'Biomarkers for ALK and ROS1 in lung cancer : immunohistochemistry and fluorescent in situ hybridization', Archives of Pathology and Laboratory Medicine, vol 142, no 8 , pp 922 - 928.
• Thunnissen, E., Allen, T., Adam, J., Aisner, D., Beasley, M., Borczuk, A., Cagle, P., Capelozzi, V., Cooper, W., Hariri, L., Kern, I., Lantuejoul, S., Miller, R., Mino-Kenudson, M., Radonic, T., Raparia, K., Rekhtman, N., Roy-Chowdhuri, S., Russell, P., Schneider, F., Sholl, L., Tsao, M., Vivero, M. and Yatabe, Y. (2018), 'Immunohistochemistry of pulmonary biomarkers a perspective from members of the pulmonary pathology society', Archives of Pathology and Laboratory Medicine, vol 142, no 3 , pp 408 - 419.
• Selinger, C., Li, B., Pavlakis, N., Links, M., Gill, A., Lee, A., Clarke, S., Tran, T., Lum, T., Yip, P., Horvath, L., Yu, B., Kohonen-Corish, M., O?Toole, S. and Cooper, W. (2017), 'Screening for ROS1 gene rearrangements in non-small cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target', Histopathology, vol 70, no 3 , pp 402 - 411.
• Selinger, C., Li, B., Pavlakis, N., Links, M., Gill, A., Lee, A., Clarke, S., Tran, T., Lum, T., Yip, P., Horvath, L., Yu, B., Kohonen-Corish, M., O?Toole, S. and Cooper, W. (2017), 'Screening for ROS1 gene rearrangements in non-small cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target', Histopathology, vol 70, no 3 , pp 402 - 411.
• Glaspole, I., Chapman, S., Cooper, W., Ellis, S., Goh, N., Hopkins, P., Macansh, S., Mahar, A., Moodley, Y., Paul, E., Reynolds, P., Walters, H., Zappala, C. and Corte, T. (2017), 'Health-related quality of life in idiopathic pulmonary fibrosis : data from the Australian IPF Registry', Respirology, vol 22, no 5 , pp 950 - 956.
• Barnet, M., O'Toole, S., Horvath, L., Selinger, C., Yu, B., Ng, C., Boyer, M., Cooper, W. and Kao, S. (2017), 'EGFR-co-mutated advanced NSCLC and response to EGFR tyrosine kinase inhibitors', Journal of Thoracic Oncology, vol 12, no 3 , pp 585 - 590.
• Shakya, R., Tarulli, G., Sheng, L., Lokman, N., Ricciardelli, C., Pishas, K., Selinger, C., Kohonen-Corish, M., Cooper, W., Turner, A., Neilsen, P. and Callen, D. (2017), 'Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer', Oncogene, vol 36, no 31 , pp 4469 - 4480.
• Kao, S., Cheng, Y., Williams, M., Kirschner, M., Madore, J., Lum, T., Sarun, K., Linton, A., McCaughan, B., Klebe, S., Zandwijk, N., Scolyer, R., Boyer, M., Cooper, W. and Reid, G. (2017), 'Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma', Journal of Thoracic Oncology, vol 12, no 9 , pp 1421 - 1433.
• Itchins, M., Chia, P., Hayes, S., Howell, V., Gill, A., Cooper, W., John, T., Mitchell, P., Millward, M., Clarke, S., Solomon, B. and Pavlakis, N. (2017), 'Treatment of ALK-rearranged non-small cell lung cancer : a review of the landscape and approach to emerging patterns of treatment resistance in the Australian context', Asia-Pacific Journal of Clinical Oncology, vol 13, no S3 , pp 3 - 13.
• Zandwijk, N., Pavlakis, N., Kao, S., Linton, A., Boyer, M., Clarke, S., Huynh, Y., Chrzanowska, A., Fulham, M., Bailey, D., Cooper, W., Kritharides, L., Ridley, L., Pattison, S., MacDiarmid, J., Brahmbhatt, H. and Reid, G. (2017), 'Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma : a first-in-man, phase 1, open-label, dose-escalation study', The Lancet Oncology, vol 18, no 10 , pp 1386 - 1396.
• Cooper, W., Russell, P., Cherian, M., Duhig, E., Godbolt, D., Jessup, P., Khoo, C., Leslie, C., Mahar, A., Moffat, D., Sivasubramaniam, V., Faure, C., Reznichenko, A., Grattan, A. and Fox, S. (2017), 'Intra- and interobserver reproducibility assessment of PD-L1 biomarker in non-small cell lung cancer', Clinical Cancer Research, vol 23, no 16 , pp 4569 - 4577.
• Herath, S. and Cooper, W. (2017), 'The novel 19G endobronchial USS (EBUS) needle samples processed as tissue "core biopsies" facilitate PD-L1 and other biomarker testing in lung cancer specimens : case report and the view point from the respiratory physician and the pathologist', Respirology Case Reports, vol 5, no 6 , pp 1 - 3.
• Satgunaseelan, L., Larsen, S., Carmalt, H. and Cooper, W. (2017), 'Spindle cell variant of diffuse large B cell lymphoma occurring in the breast', Pathology, vol 49, no 7 , pp 784 - 786.
• Szczepny, A., Rogers, S., Jayasekara, W., Park, K., McCloy, R., Cochrane, C., Ganju, V., Cooper, W., Sage, J., Peacock, C., Cain, J., Burgess, A. and Watkins, D. (2017), 'The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer', Oncogene, vol 36, no 39 , pp 5544 - 5550.
• Thunnissen, E., Borczuk, A., Flieder, D., Witte, B., Beasley, M., Chung, J., Dacic, S., Lantuejoul, S., Russell, P., Bakker, M., Botling, J., Brambilla, E., Cuba, E., Geisinger, K., Hiroshima, K., Marchevsky, A., Minami, Y., Moreira, A., Nicholson, A., Yoshida, A., Tsao, M., Warth, A., Duhig, E., Chen, G., Matsuno, Y., Travis, W., Butnor, K., Cooper, W., Mino-Kenudson, M., Motoi, N., Poleri, C., Pelosi, G., Kerr, K., Aisner, S., Ishikawa, Y., Buettner, R., Keino, N., Yatabe, Y. and Noguchi, M. (2017), 'The use of immunohistochemistry improves the diagnosis of small cell lung cancer and its differential diagnosis : an international reproducibility study in a demanding set of cases', Journal of Thoracic Oncology, vol 12, no 2 , pp 334 - 346.
• Jo, H., Glaspole, I., Grainge, C., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Chapman, S., Walters, E., Zappala, C., Allan, H., Keir, G., Hayen, A., Cooper, W., Mahar, A., Ellis, S., Macansh, S. and Corte, T. (2017), 'Baseline characteristics of idiopathic pulmonary fibrosis : analysis from the Australian Idiopathic Pulmonary Fibrosis Registry', European Respiratory Journal, vol 49, no 2 .
• Lyle, M., Haydu, L., Menzies, A., Thompson, J., Saw, R., Spillane, A., Kefford, R., Mann, G., Cooper, W., Yu, B., Scolyer, R., O'Toole, S. and Long, G. (2016), 'The molecular profile of metastatic melanoma in Australia', Pathology, vol 48, no 2 , pp 188 - 193.
• Tran, T., Selinger, C., Kohonen-Corish, M., McCaughan, B., Kennedy, C., O'Toole, S. and Cooper, W. (2016), 'Alterations of MET gene copy number and protein expression in primary non-small-cell lung cancer and corresponding nodal metastases', Clinical Lung Cancer, vol 17, no 1 , pp 30 - 38.
• Anderson, S., Sasson, S., Lee, F., Cooper, W., Larsen, S. and Garsia, R. (2016), 'Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman's disease : a case report', BMC Infectious Diseases, vol 16, no 1 .
• Kao, S., Kirschner, M., Cooper, W., Tran, T., Burgers, S., Wright, C., Korse, T., Broek, D., Edelman, J., Vallely, M., McCaughan, B., Pavlakis, N., Clarke, S., Molloy, M., Zandwijk, N. and Reid, G. (2016), 'A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma', British Journal of Cancer, vol 114, no 5 , pp 524 - 531.
• Bremnes, R., Busund, L., Kilv?r, T., Andersen, S., Richardsen, E., Paulsen, E., Hald, S., Khanehkenari, M., Cooper, W., Kao, S. and Donnem, T. (2016), 'The role of tumor infiltrating lymphocytes in development, progression and prognosis of non-small cell lung cancer', Journal of Thoracic Oncology, vol 11, no 6 , pp 789 - 800.
• Vargas, A., Selinger, C., Satgunaseelan, L., Cooper, W., Gupta, R., Stalley, P., Brown, W., Soper, J. and et al, .. (2016), 'Atypical Ewing sarcoma breakpoint region 1 fluorescence in-situ hybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases', Histopathology, vol 69, no 6 , pp 1000 - 1011.
• Kakavand, H., Walker, E., Lum, T., Wilmott, J., Selinger, C., Smith, E., Saw, R., Yu, B., Cooper, W., Long, G., O'Toole, S. and Scolyer, R. (2016), 'BRAFV600E and NRASQ61L/Q61R mutation analysis in metastatic melanoma using immunohistochemistry : a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting', Histopathology, vol 69, no 4 , pp 680 - 686.
• Jo, H., Glaspole, I., Levin, K., McCormack, S., Mahar, A., Cooper, W., Cameron, R., Ellis, S., Cottee, A., Webster, S., Troy, L., Torzillo, P., Corte, P., Symons, K., Taylor, N. and Corte, T. (2016), 'Clinical impact of the interstitial lung disease multidisciplinary service', Respirology, vol 21, no 8 , pp 1438 - 1444.
• Kao, S., Fulham, M., Wong, K., Cooper, W., Brahmbhatt, H., MacDiarmid, J., Pattison, S., Sagong, J., O'Brien, C., Huynh, Y., Pavlakis, N., Clarke, S., Boyer, M., Reid, G. and Zandwijk, N. (2015), 'A significant metabolic and radiological response after a novel targeted microRNA-based treatment approach in malignant pleural mesothelioma', American Journal of Respiratory and Critical Care Medicine, vol 191, no 12 , pp 1467 - 1469.
• Cooper, W., Tran, T., Vilain, R., Madore, J., Selinger, C., Kohonen-Corish, M., Yip, P., Yu, B., O'Toole, S., McCaughan, B., Yearley, J., Horvath, L., Kao, S., Boyer, M. and Scolyer, R. (2015), 'PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma', Lung Cancer, vol 89, no 2 , pp 181 - 188.
• Selinger, C., Cooper, W., Lum, T., McNeil, C., Morey, A., Waring, P., Amanuel, B., Millward, M., Peverall, J., Vliet, C., Christie, M., Tran, Y., Diakos, C., Pavlakis, N., Gill, A. and O'Toole, S. (2015), 'Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing', Histopathology, vol 67, no 5 , pp 654 - 663.
• Li, B., Lee, A., O'Toole, S., Cooper, W., Yu, B., Chaft, J., Arcila, M., Kris, M. and Pavlakis, N. (2015), 'HER2 insertion YVMA mutant lung cancer : long natural history and response to afatinib', Lung Cancer, vol 90, no 3 , pp 617 - 619.
• Wang, S., Yu, B., Ng, C., Mercorella, B., Selinger, C., O'Toole, S. and Cooper, W. (2015), 'The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer', Translational Lung Cancer Research, vol 4, no 2 , pp 119 - 125.
• Luk, P., Yu, B., Ng, C., Mercorella, B., Selinger, C., Lum, T., Kao, S., O'Toole, S. and Cooper, W. (2015), 'BRAF mutations in non-small cell lung cancer', Translational Lung Cancer Research, vol 4, no 2 , pp 142 - 148.
• Williams, M., Kirschner, M., Cheng, Y., Hanh, J., Weiss, J., Mugridge, N., Wright, C., Kao, S., Edelman, J., Vallely, M., McCaughan, B., Cooper, W., Klebe, S., Lin, R., Brahmbhatt, H., MacDiarmid, J., Zandwijk, N. and Reid, G. (2015), 'miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma', Oncotarget, vol 6, no 27 , pp 23480 - 23495.
• Williams, M., Kirschner, M., Cheng, Y., Hanh, J., Weiss, J., Mugridge, N., Wright, C., Kao, S., Edelman, J., Vallely, M., McCaughan, B., Cooper, W., Klebe, S., Lin, R., Brahmbhatt, H., MacDiarmid, J., Zandwijk, N. and Reid, G. (2015), 'miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma', Oncotarget, vol 6, no 27 , pp 23480 - 23495.
• Yip, P., Cooper, W., Kohonen-Corish, M., Lin, B., McCaughan, B., Boyer, M., Kench, J. and Horvath, L. (2014), 'Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer', Journal of Clinical Pathology, vol 67, no 4 , pp 333 - 340.
• Cooper, W., Fox, S., O'Toole, S., Morey, A., Frances, G., Pavlakis, N., O'Byrne, K., Dettrick, A., Leong, T., Rathi, V., Spagnolo, D., Hemmings, C., Singh, M., Moffat, D., Tsao, M., Wilner, K., Buller, R., Pitman Lowenthal, S., Arifeen, S., Binko, J. and Alam, M. (2014), 'National Working Group Meeting on ALK Diagnostics in Lung Cancer', Asia-Pacific Journal of Clinical Oncology, vol 10, no Suppl. 2 , pp 11 - 17.
• Houang, M., Toon, C., Clarkson, A., Sioson, L., Watson, N., Farzin, M., Selinger, C., Chou, A., Morey, A., Cooper, W., O'Toole, S. and Gill, A. (2014), 'Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer', Pathology, vol 46, no 5 , pp 383 - 388.
• Houang, M., Sioson, L., Clarkson, A., Watson, N., Farzin, M., Toon, C., Raut, A., O'Toole, S., Cooper, W., Pavlakis, N., Mead, S., Chou, A. and Gill, A. (2014), 'EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer', Pathology, vol 46, no 6 , pp 501 - 508.
• O'Toole, S., Yu, B. and Cooper, W. (2014), 'Molecular diagnosis in cytology and its place in the new classification : a pactical guide', Journal of OncoPathology, vol 2, no 1 , pp 63 - 73.
• Moodley, Y., Goh, N., Glaspole, I., Macansh, S., Haydn, W., Chapman, S., Hopkins, P., Reynolds, P., Zappala, C., Cooper, W., Mahar, A., Ellis, S., Mccormack, S., Darbishire, W., Wood-Baker, R. and Corte, T. (2014), 'Australian Idiopathic Pulmonary Fibrosis Registry : vital lessons from a national prospective collaborative project', Respirology, vol 19, no 7 , pp 1088 - 1091.
• Tran, T., Selinger, C., Yu, B., Ng, C., Kohonen-Corish, M., McCaughan, B., Kennedy, C., O'Toole, S. and Cooper, W. (2014), 'Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer', Journal of Clinical Pathology, vol 67, no 11 , pp 985 - 991.
• Carlino, M., Haydu, L., Kakavand, H., Menzies, A., Hamilton, A., Yu, B., Ng, C., Cooper, W., Thompson, J., Kefford, R., O'Toole, S., Scolyer, R. and Long, G. (2014), 'Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma', British Journal of Cancer, vol 111, no 2 , pp 292 - 299.
• Yip, P., Yu, B., Cooper, W., Selinger, C., Ng, C., Kennedy, C., Kohonen-Corish, M., McCaughan, B., Trent, R., Boyer, M., Kench, J., Horvath, L. and O'Toole, S. (2013), 'Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma', Journal of Thoracic Oncology, vol 8, no 4 , pp 408 - 414.
• Cooper, W., Yu, B., Yip, P., Ng, C., Lum, T., Farzin, M., Trent, R., Mercorella, B., Clarkson, A., Kohonen-Corish, M., Horvath, L., Kench, J., McCaughan, B., Gill, A. and O'Toole, S. (2013), 'EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma', Journal of Clinical Pathology, vol 66, no 9 , pp 744 - 748.
• Tran, T., Selinger, C., Kohonen-Corish, M., McCaughan, B., Kennedy, C., O'Toole, S. and Cooper, W. (2013), 'Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer', Lung Cancer, vol 81, no 3 , pp 462 - 467.
• Cooper, W. and O'Toole, S. (2013), 'Molecular pathology in lung cancer', Cancer Forum, vol 37, no 2 .
• Cooper, W., Lam, D., O'Toole, S. and Minna, J. (2013), 'Molecular biology of lung cancer', Journal of Thoracic Disease, vol 5, no Suppl. 5 , pp 479 - 490.
• Selinger, C., Rogers, T., Russell, P., O'Toole, S., Yip, P., Wright, G., Wainer, Z., Horvath, L., Boyer, M., McCaughan, B., Kohonen-Corish, M., Fox, S., Cooper, W. and Solomon, B. (2013), 'Testing for ALK rearrangement in lung adenocarcinoma : a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization', Modern Pathology, vol 26, no 12 , pp 1545 - 1553.
• Poursoltan, P., Currey, N., Pangon, L., Kralingen, C., Selinger, C., Mahar, A., Cooper, W., Kennedy, C., McCaughan, B., Trent, R. and Kohonen-Corish, M. (2012), 'Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer', Lung Cancer, vol 77, no 2 , pp 272 - 276.
• Hollingsworth, J., Cooper, W., Nicolls, K., Wills, E., Thiruvilangam, V., Lee, S. and Scolyer, R. (2011), 'Follicular dendritic cell sarcoma of the lung: a report of two cases highlighting its pathological features and diagnostic pitfalls', Pathology, vol 43, no 1 , pp 67 - 70.
• Selinger, C., Cooper, W., Al-Sohaily, S., Mladenova, D., Pangon, L., Kennedy, C., Mccaughan, B., Stirzaker, C. and Kohonen-Corish, M. (2011), 'Loss of special at-rich binding protein 1 expression is a marker of poor survival in lung cancer', Journal of Thoracic Oncology, vol 6, no 7 , pp 1179 - 1189.
• Selinger, C., Cooper, W., Al-Sohaily, S., Mladenova, D., Pangon, L., Kennedy, C., Mccaughan, B., Stirzaker, C. and Kohonen-Corish, M. (2011), 'Loss of special at-rich binding protein 1 expression is a marker of poor survival in lung cancer', Journal of Thoracic Oncology, vol 6, no 7 , pp 1179 - 1189.
• Cooper, W., O'Toole, S., Boyer, M., Horvath, L. and Mahar, A. (2011), 'What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements', Pathology, vol 43, no 2 , pp 103 - 115.
• Verwer, N., Murali, R., Winstanley, J., Cooper, W., Stretch, J., Thompson, J. and Scolyer, R. (2010), 'Lymphoma occurring in patients with cutaneous melanoma', Journal of Clinical Pathology, vol 63, no 9 , pp 777 - 781.
• Cooper, W., Kohonen-Corish, M., Mccaughan, B., Kennedy, C., Sutherland, R. and Lee, S. (2009), 'Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer', Histopathology, vol 55, no 1 , pp 28 - 36.
• Zhuang, L., Scolyer, R., Lee, S., Mccarthy, S., Cooper, W., Zhang, X., Thompson, J. and Hersey, P. (2009), 'Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma', Histopathology, vol 54, no 4 , pp 462 - 470.
• Seng, T., Currey, N., Cooper, W., Lee, C., Chan, C., Horvath, L., Sutherland, R., Kennedy, C., McCaughan, B. and Kohonen-Corish, M. (2008), 'DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma', British Journal of Cancer, vol 99 , pp 375 - 382.
• Cooper, W., Kohonen-Corish, M., Zhuang, L., Mccaughan, B., Kennedy, C., Screaton, G., Sutherland, R. and Lee, S. (2008), 'Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions', Cancer, vol 113, no 1 , pp 135 - 142.
• Shin, J., Spillane, A., Wills, E. and Cooper, W. (2008), 'PEComa of the retroperitoneum [7]', Pathology, , pp 93 - 95.
• Cooper, C., Joshua, D., Lee, S., Eyers, A. and Cooper, W. (2007), 'Extranodal plasmablastic lymphoma arising in mantle cell lymphoma [6]', Histopathology, vol 51, no 6 , pp 856 - 859.